BGI suspends non-invasive fetal trisomy test in Mainland China

Following a decision by China Food and Drug Administration in February 2014 to regulate genetic testing, BGI has anounced to suspend prenatal testing but continue to use the test after birth. BGI is now in the process of product registration according to CFDA provisions

BGI news release, March 13, 2014

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny